Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Maura Gillison, MD, PhD
RTOG Foundation
Principal Investigator - Robert Ferris, MD, PhD
RTOG Foundation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford Cancer Institute
Palo Alto, California, United States
- University of Florida Cancer Center at Orlando Health
Orlando, Florida, United States
- Emory University/winship Cancer Institute
Atlanta, Georgia, United States
- University of Louisville
Louisville, Kentucky, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- Upmc - Shadyside Hospital
Pittsburgh, Pennsylvania, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Inova Fairfax Hospital
Falls Church, Virginia, United States
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2016
- Primary completion
- 25 Sept 2018
- Completion
- 21 Feb 2022
- Last update posted
- 29 Nov 2022
- Registered enrollment
- 40
- Registry id
- NCT02764593
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.